General issues on microbial translocation in HIV-infected patients.

Area of Science:

• Gastroenterology
• Immunology
• Microbiology

Background:

• The gastrointestinal tract harbors a vast number of bacteria, serving as a major source of microbial products.
• Damage to the gut's immune and epithelial components can lead to increased translocation of these products.

Purpose of the Study:

• To explore the role of microbial translocation in HIV infection and chronic viral hepatitis.
• To investigate how gut barrier integrity impacts systemic immune activation in HIV.

Main Methods:

• The study defines microbial translocation as the passage of microbes and microbial products across the intestinal barrier.
• It reviews the impact of gut microbiota on immune responses during chronic HIV infection.

Main Results:

• Increased translocation of luminal microbial products can affect systemic immune activation in chronic HIV.
• Microbial translocation may be a key factor accelerating the progression of chronic viral hepatitis in HIV patients.

Conclusions:

• Advancements in microbiota research may aid in controlling HIV disease progression.
• The complexity and individual diversity of the gut microbiota present challenges in managing HIV and associated conditions.